A team of researchers from Baidu Research, an AI company based in Beijing, has developed an AI algorithm that can rapidly design highly stable COVID-19 mRNA vaccine sequences that were previously unattainable.
HKEx revealed on September 12th that AIM Vaccine Co., Ltd., submitted an IPO application to the main board of the HKEx, with Goldman, CICC, China Securities International and Macquarie Group as its co-sponsors.
In last week’s VC news, pharmaceutical firm Stemirna Therapeutics raises roughly $188 million for COVID vaccine trials, Xiaomi-backed fund invests in autonomous driving startup Zongmu Technology shortly after the company announced a foray into the EV market, supply chain information startup Xforceplus closes $200 million Series C round.
In last week’s VC news: Shenzhen Tengyin raises roughly $15 million in a Series A+ round, EdiGene bags $62 million, while Liaye, founded by former Baidu employees, raises $50 million.
The Chinese government has granted conditional approval to its first homegrown coronavirus vaccine developed by state-owned pharmaceutical giant Sinopharm, health officials announced Thursday.